Norwegian-French mini symposium on rare neurodegenerative diseases and neurogenetics

Friday 12 December - Saturday 13 December 2003

Auditorium, 4th floor, “Medisinsk bygning” – Ullevål University Hospital, entrance opposite KIWI grocery store.

Please confirm your attendance to by email to chantal.tallaksen@ulleval.no, or by fax to +47 22115949.

Programme

Friday 12 December

13.30 – 14.00 Alexis Brice, Department of genetics, Hôpital Pitié-Salpêtrière, Paris

New tools and new challenges in neurogenetics

A brief survey of new technological assays and methods in molecular biology, both for cellular studies and animal models, with comments on their potential and limitations for further progress in neurogenetics. The methods accessible at the Unit 289 of the Salpêtrière Hospital will be specially presented.

14.00-14.15 Giovanni Stevanin, INSERM Research Unit 289, Hôpital Pitié-Salpêtrière, Paris

Neurogenetics of spinocerebellar degenerations

Key features of neurodegenerative disorders associated with triplets repeats and polyglutamine expansions, and implications for further research topics.

14.15 – 14.30 Ole P. Ottersen, CMBN

Presentation of the Center for Molecular Biology and Neuroscience (CMBN)

14.30 – 14.45 Erling Seeberg, CMBN and Institute of Medical Microbiology, Rikshospitalet

Novel DNA and RNA repair mechanisms

14.45 – 15.00 Tone Tønjum, CMBN and Institute of Medical Microbiology, Rikshospitalet

Genome instability and neurodegenerative disease – what can we learn from microbial model organisms?

15.00 – 15.15 Coffee break

15.15 – 15.30 Arne Klungland, CMBN and Institute of Medical Microbiology, Rikshospitalet

DNA repair and genomic instability

15.30 – 15.45 Niels Christian Danbolt, CMBN and Department of Anatomy

Glutamate transport and neurological disease

15.45 – 16.00 Alexandra Durr, Department of Genetics and Research Unit 289,
Hospital Pitié Salpêtrière, Paris

How can or should clinicians, geneticists and molecular biologists work together in neurogenetics?

Progress in neurogenetics has been largely a result of a synergism between clinicians, molecular biologists and geneticists. How can one best achieve such a multidisciplinary approach? How can such different participants speak a common language?

16.00 – 17.00 Coffee break and discussions – possible collaborative projects on the basis of the afternoon’s presentations.

19.30 Dinner - Lofoten restaurant (Speakers only)

Saturday 13 December

10.00 – 13.00 Visit and meetings at Ullevål University Hospital, Department of Neurology and Department of Medical Genetics, CMBN, and Rikshospitalet.

 

13.00 – 15.00 Lunch and final brain storming session with conclusions of the meeting.